A Preview Of PDS Biotechnology's Earnings
Portfolio Pulse from Benzinga Insights
PDS Biotechnology (NASDAQ:PDSB) is scheduled to release its quarterly earnings report on Tuesday, 2023-11-14, with analysts expecting an EPS of $-0.45. Investors are looking for an earnings beat and positive guidance for the next quarter. In the past, PDSB's stock price has been influenced more by guidance than earnings beats or misses. Last quarter, PDSB met the EPS estimate, resulting in a 10.32% stock price increase the following day. Over the last year, PDSB shares have declined by 40.38%, indicating potential concern among long-term shareholders ahead of the earnings release.
November 13, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
PDS Biotechnology is expected to report an EPS of $-0.45 for the upcoming earnings, with a focus on guidance for future quarters. Historical data shows significant stock price movements post-earnings release.
The expected EPS is already factored into the stock price, but the guidance provided will be key for investor sentiment. Historical performance indicates that the stock price is sensitive to earnings reports, but the recent downward trend suggests caution among investors. The score is neutral due to the uncertainty of the earnings outcome and its impact.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100